Mammographic screening and risk factors for breast cancer.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMC 2800262)

Published in Am J Epidemiol on October 29, 2009

Authors

Nancy R Cook1, Bernard A Rosner, Susan E Hankinson, Graham A Colditz

Author Affiliations

1: Division of Preventive Medicine, Brigham and Women's Hospital, 900 Commonwealth Avenue East, Boston, MA 02215, USA. ncook@rics.bwh.harvard.edu

Articles citing this

Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial. Lancet Oncol (2012) 3.56

Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to the time since the mammogram. Cancer Epidemiol Biomarkers Prev (2013) 0.91

Family history of cancer and its association with breast cancer risk perception and repeat mammography. Am J Public Health (2012) 0.86

Dietary fat intake in relation to lethal breast cancer in two large prospective cohort studies. Breast Cancer Res Treat (2014) 0.83

Variation in Breast Cancer-Risk Factor Associations by Method of Detection: Results From a Series of Case-Control Studies. Am J Epidemiol (2015) 0.83

Digoxin use and risk of invasive breast cancer: evidence from the Nurses' Health Study and meta-analysis. Breast Cancer Res Treat (2014) 0.82

Performance of the Breast Cancer Risk Assessment Tool Among Women Age 75 Years and Older. J Natl Cancer Inst (2015) 0.79

Invited commentary: screening and the elusive etiology of prostate cancer. Am J Epidemiol (2015) 0.77

Menopausal hormone therapy and breast cancer mortality: clinical implications. Ther Adv Drug Saf (2015) 0.75

Hypertension and breast cancer risk: a systematic review and meta-analysis. Sci Rep (2017) 0.75

Breast cancer mortality in relation to receipt of screening mammography: a case-control study in Saskatchewan, Canada. Cancer Causes Control (2014) 0.75

Accounting for individualized competing mortality risks in estimating postmenopausal breast cancer risk. Breast Cancer Res Treat (2016) 0.75

Articles cited by this

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37

Marginal structural models and causal inference in epidemiology. Epidemiology (2000) 33.54

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst (1989) 19.87

Causal diagrams for epidemiologic research. Epidemiology (1999) 19.48

Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med (2005) 16.70

Identifiability and exchangeability for direct and indirect effects. Epidemiology (1992) 14.88

The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet (1997) 10.28

Estimating causal effects from epidemiological data. J Epidemiol Community Health (2006) 5.61

Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst (2006) 5.17

Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst (2007) 5.08

Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med (2008) 4.81

Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst (2004) 4.57

Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA (2008) 4.42

Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol (2000) 3.94

A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA (1991) 3.07

Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study. Am J Epidemiol (2008) 3.05

Estrogen plus progestin therapy and breast cancer in recently postmenopausal women. Am J Epidemiol (2008) 2.79

Trends in self-reported use of mammograms (1989-1997) and Papanicolaou tests (1991-1997)--Behavioral Risk Factor Surveillance System. MMWR CDC Surveill Summ (1999) 2.77

Reduced screening mammography among women with diabetes. Arch Intern Med (2005) 2.44

Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study. Am J Epidemiol (2002) 2.02

Body weight and cancer screening among women. J Womens Health Gend Based Med (2001) 1.66

Use of mammograms among women aged > or = 40 years--United States, 2000-2005. MMWR Morb Mortal Wkly Rep (2007) 1.64

Adjusting for screening history in epidemiologic studies of cancer: why, when, and how to do it. Am J Epidemiol (2003) 1.43

Obesity and breast cancer screening. J Gen Intern Med (2004) 1.38

Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States). Cancer Causes Control (1994) 1.34

Postmenopausal hormone use, screening, and breast cancer: characterization and control of a bias. Epidemiology (2001) 1.28

The influence of health status, age, and race on screening mammography in elderly women. Arch Intern Med (2005) 1.17

Ethnic differences in the use of regular mammography: the multiethnic cohort. Breast Cancer Res Treat (2008) 0.92

Invited commentary: screening as a nuisance variable in cancer epidemiology: methodological considerations. Am J Epidemiol (2003) 0.91

'Weighing in' on screening mammography. Breast Cancer Res Treat (2008) 0.85

On informative detection bias in screening studies. Stat Med (2008) 0.78

Articles by these authors

Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96

Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94

Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA (2004) 11.69

Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA (2003) 10.05

Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst (2004) 8.77

Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71

Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med (2004) 8.63

Physical activity and survival after breast cancer diagnosis. JAMA (2005) 8.60

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39

The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer (2005) 8.19

Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med (2013) 7.72

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30

Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr (2002) 6.96

Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA (2005) 6.89

Insulin-like growth factors and neoplasia. Nat Rev Cancer (2004) 6.29

Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22

Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86

Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79

Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol (2006) 5.22

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14

A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89

Merging and emerging cohorts: not worth the wait. Nature (2007) 4.66

A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet (2008) 4.57

Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst (2004) 4.57

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54

Aspirin intake and survival after breast cancer. J Clin Oncol (2010) 4.50

Increasing burden of melanoma in the United States. J Invest Dermatol (2009) 4.43

Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA (2011) 4.25

Comparison of risk factors for colon and rectal cancer. Int J Cancer (2004) 4.03

Estimating the number of deaths due to obesity: can the divergent findings be reconciled? J Womens Health (Larchmt) (2007) 3.86

Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81

Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol (2006) 3.79

Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst (2005) 3.75

Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69

Smoking and smoking cessation in relation to mortality in women. JAMA (2008) 3.68

Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst (2006) 3.65

Leisure time spent sitting in relation to total mortality in a prospective cohort of US adults. Am J Epidemiol (2010) 3.64

Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst (2003) 3.54

The epidemic of obesity. J Clin Endocrinol Metab (2004) 3.53

A prospective study of aspirin use and the risk of pancreatic cancer in women. J Natl Cancer Inst (2004) 3.49

A prospective study of aspirin use and the risk for colorectal adenoma. Ann Intern Med (2004) 3.46

Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst (2004) 3.43

Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol (2006) 3.41

Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation (2006) 3.39

Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet (2010) 3.37

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37

Relation between dieting and weight change among preadolescents and adolescents. Pediatrics (2003) 3.36

Suicide rates among physicians: a quantitative and gender assessment (meta-analysis). Am J Psychiatry (2004) 3.31

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst (2004) 3.28

Maternal gestational diabetes, birth weight, and adolescent obesity. Pediatrics (2003) 3.27

Sexual orientation and tobacco use in a cohort study of US adolescent girls and boys. Arch Pediatr Adolesc Med (2004) 3.20

Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med (2004) 3.18

American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16

Adult weight change and risk of postmenopausal breast cancer. JAMA (2006) 3.11

Caregiving and risk of coronary heart disease in U.S. women: a prospective study. Am J Prev Med (2003) 3.10

A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res (2007) 3.08

Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care (2006) 3.06

Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nat Genet (2009) 3.06

Obesity and cancer. Oncologist (2010) 3.01

The role of prolactin in mammary carcinoma. Endocr Rev (2003) 2.95

Low-carbohydrate diets and all-cause and cause-specific mortality: two cohort studies. Ann Intern Med (2010) 2.95

Breast-feeding and risk for childhood obesity: does maternal diabetes or obesity status matter? Diabetes Care (2006) 2.93

Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst (2003) 2.92

Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol (2003) 2.90

Vitamin A intake and hip fractures among postmenopausal women. JAMA (2002) 2.90

Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst (2003) 2.87

Active and passive smoking in breast cancer: prospective results from the Nurses' Health Study. Epidemiology (2002) 2.86

Sugar-added beverages and adolescent weight change. Obes Res (2004) 2.82

Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am J Clin Nutr (2005) 2.82

A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol (2007) 2.80

Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA (2005) 2.76

Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev (2004) 2.75

Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol (2004) 2.72

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res (2008) 2.69

Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis. J Natl Cancer Inst (2008) 2.69

Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Arch Intern Med (2005) 2.66

Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum (2004) 2.62

Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst (2002) 2.59

Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr (2007) 2.56

Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst (2004) 2.54

Long-term aspirin use and mortality in women. Arch Intern Med (2007) 2.54

Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation (2003) 2.52

A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol (2007) 2.50

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45

Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 2.37

Risk factors for skin cancers: a nested case-control study within the Nurses' Health Study. Int J Epidemiol (2006) 2.36